Up-titration of guideline-directed medical therapy (GDMT) after transcatheter edge-to-edge mitral valve repair (M-TEER) may be independently associated with a reduced risk of clinical events including mortality and heart failure (HF) hospitalization, according to a new analysis of EuroSMR registry data.